Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Beyond Lipids: The Role in Oxidative Stress and Thrombosis.
anti-PCSK9
oxidative stress
platelets
proprotein convertase subtilisin/kexin type 9 (PCSK9)
thrombosis
Journal
Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981
Informations de publication
Date de publication:
16 Mar 2022
16 Mar 2022
Historique:
received:
24
02
2022
revised:
11
03
2022
accepted:
15
03
2022
entrez:
25
3
2022
pubmed:
26
3
2022
medline:
26
3
2022
Statut:
epublish
Résumé
Proprotein convertase subtilisin/kexin type 9 (PCSK9), mainly secreted in the liver, is a key regulator of cholesterol homeostasis inducing LDL receptors' degradation. Beyond lipid metabolism, PCSK9 is involved in the development of atherosclerosis, promoting plaque formation in mice and human, impairing the integrity of endothelial monolayer and promoting the events that induce atherosclerosis disease progression. In addition, the PCSK9 ancillary role in the atherothrombosis process is widely debated. Indeed, recent evidence showed a regulatory effect of PCSK9 on redox system and platelet activation. In particular, the role of PCSK9 in the activation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Nox2) system, of MAP-kinase cascades and of CD36 and LOX-1 downstream pathways, suggests that PCSK9 may be a significant cofactor in atherothrombosis development. This evidence suggests that the serum levels of PCSK9 could represent a new biomarker for the occurrence of cardiovascular events. Finally, other evidence showed that PCSK9 inhibitors, a novel pharmacological tool introduced in clinical practice in recent years, counteracted these phenomena. In this review, we summarize the evidence concerning the role of PCSK9 in promoting oxidative-stress-related atherothrombotic process.
Identifiants
pubmed: 35326219
pii: antiox11030569
doi: 10.3390/antiox11030569
pmc: PMC8945358
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
J Exp Med. 2012 Apr 9;209(4):819-35
pubmed: 22451716
N Engl J Med. 2015 Apr 16;372(16):1489-99
pubmed: 25773378
Drug Des Devel Ther. 2013 Oct 04;7:1135-48
pubmed: 24115837
Circulation. 2004 Sep 7;110(10):1326-9
pubmed: 15249506
Blood. 2014 May 1;123(18):2759-67
pubmed: 24585776
Atherosclerosis. 2003 May;168(1):1-14
pubmed: 12732381
Int J Mol Sci. 2021 Jul 03;22(13):
pubmed: 34281247
Biomed Pharmacother. 2019 Feb;110:456-464
pubmed: 30530048
Eur Heart J. 2020 Jun 21;41(24):2313-2330
pubmed: 32052833
Eur J Pharmacol. 2020 Jul 5;878:173114
pubmed: 32302598
Cardiovasc Res. 2018 Jul 1;114(8):1145-1153
pubmed: 29617722
Nutr Metab Cardiovasc Dis. 2020 Feb 10;30(2):282-291
pubmed: 31653513
Antioxid Redox Signal. 2015 Mar 20;22(9):760-71
pubmed: 25490141
Circulation. 2021 Jan 5;143(1):45-61
pubmed: 32988222
Thromb Haemost. 2010 Jan;103(1):56-61
pubmed: 20062938
Circulation. 2010 Mar 2;121(8):1033-44
pubmed: 20194876
N Engl J Med. 2008 Aug 28;359(9):938-49
pubmed: 18753650
Diabetes. 2014 Mar;63(3):976-81
pubmed: 24353177
N Engl J Med. 2015 Apr 16;372(16):1500-9
pubmed: 25773607
Antioxid Redox Signal. 2010 Apr 15;12(8):1009-59
pubmed: 19686040
Atherosclerosis. 2016 May;248:117-22
pubmed: 27015246
Clin Immunol. 2008 Feb;126(2):155-64
pubmed: 18037347
Blood. 1998 Jan 15;91(2):484-90
pubmed: 9427701
Nat Rev Immunol. 2016 Aug;16(8):485-97
pubmed: 27346802
Eur Heart J. 2020 Jan 21;41(4):543-603
pubmed: 31504429
Oxid Med Cell Longev. 2016;2016:1245049
pubmed: 27478531
Atherosclerosis. 2019 Oct;289:195-200
pubmed: 31303312
Semin Thromb Hemost. 2005;31(4):381-92
pubmed: 16149014
Arch Physiol Biochem. 2020 Jul 3;:1-6
pubmed: 32619370
Front Cardiovasc Med. 2021 Jun 21;8:684920
pubmed: 34235190
Eur J Clin Invest. 2021 Apr;51(4):e13459
pubmed: 33236356
J Am Coll Cardiol. 2017 Sep 19;70(12):1455-1462
pubmed: 28911508
N Engl J Med. 2018 Nov 29;379(22):2097-2107
pubmed: 30403574
Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):928-33
pubmed: 12552133
Can J Physiol Pharmacol. 2017 Mar;95(3):268-274
pubmed: 28134561
N Engl J Med. 2017 May 4;376(18):1713-1722
pubmed: 28304224
Nat Rev Immunol. 2011 Apr;11(4):264-74
pubmed: 21436837
Eur Heart J. 2016 Feb 7;37(6):546-53
pubmed: 26655339
Thromb Res. 1987 Sep 15;47(6):647-56
pubmed: 3686481
Circ Res. 2007 Jan 5;100(1):27-40
pubmed: 17204662
J Am Coll Cardiol. 2018 Dec 25;72(25):3320-3331
pubmed: 30415883
J Atheroscler Thromb. 2015;22(1):76-84
pubmed: 25185779
Antioxidants (Basel). 2021 Jan 20;10(2):
pubmed: 33498338
Curr Opin Lipidol. 2012 Oct;23(5):439-45
pubmed: 22777292
J Am Coll Cardiol. 2018 Feb 27;71(8):952-954
pubmed: 29471945
Nat Commun. 2018 Nov 30;9(1):5116
pubmed: 30504805
Am J Cardiol. 2003 Feb 6;91(3A):7A-11A
pubmed: 12645638
Can J Cardiol. 2011 Sep-Oct;27(5):635-62
pubmed: 21963058
Curr Atheroscler Rep. 2014 Apr;16(4):401
pubmed: 24504549
Nat Med. 2007 Sep;13(9):1086-95
pubmed: 17721545
J Atheroscler Thromb. 2015;22(3):221-30
pubmed: 25410128
J Intern Med. 2020 Jun;287(6):746-747
pubmed: 32242993
N Engl J Med. 2005 Apr 21;352(16):1685-95
pubmed: 15843671
Atherosclerosis. 2014 Nov;237(1):108-16
pubmed: 25238217
Cardiovasc Res. 2015 Sep 1;107(4):556-67
pubmed: 26092101
Mol Aspects Med. 2009 Feb-Apr;30(1-2):1-12
pubmed: 18796312
Arterioscler Thromb Vasc Biol. 2017 Feb;37(2):218-225
pubmed: 27932349
Oxid Med Cell Longev. 2017;2017:8416763
pubmed: 28819546
Int J Mol Sci. 2021 Oct 16;22(20):
pubmed: 34681838
Circ Res. 2016 Feb 19;118(4):732-49
pubmed: 26892970
Arterioscler Thromb Vasc Biol. 2014 Mar;34(3):571-80
pubmed: 24371083
Pharmacol Rev. 2017 Jan;69(1):33-52
pubmed: 27920219
Eur Heart J. 2017 Aug 21;38(32):2459-2472
pubmed: 28444290
Circ Res. 2003 Dec 12;93(12):1225-32
pubmed: 14593003
Vascul Pharmacol. 2017 Oct 19;:
pubmed: 29056472
Oxid Med Cell Longev. 2021 Jul 20;2021:6677012
pubmed: 34336112
Curr Opin Hematol. 2019 Sep;26(5):357-365
pubmed: 31261174
Blood. 2015 Apr 23;125(17):2693-703
pubmed: 25710879
Int J Cardiol. 2017 Jan 15;227:644-649
pubmed: 27810295
Antioxidants (Basel). 2020 Apr 02;9(4):
pubmed: 32252393
Basic Res Cardiol. 2017 May;112(3):32
pubmed: 28439730
Sci Rep. 2019 Nov 20;9(1):17167
pubmed: 31748600